REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Biosequence S.A.S. (Ecuador)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Research and Development in Nanotechnology
Full name: Biosequence S.A.S. Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Biosequence S.A.S. is a company in Ecuador, with a head office in Quito. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. Biosequence S.A.S. was incorporated on July 08, 2020. 6 (2024) employees currently work for Biosequence S.A.S.. In 2024, the company reported a net sales revenue increase of 95.09%. Its’ total assets recorded a negative growth of 27.77%. The enterprise’s net profit margin decreased by 0.48% in 2024.

Headquarters
Av. Checoslovaquia E10-195, Cuarzo Bldg. , Floor 301
Quito; Pichincha;

Contact Details: Purchase the Biosequence S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Biosequence S.A.S. report to view the information.
Registered Capital:
Purchase the Biosequence S.A.S. report to view the information.
Financial Auditors:
Purchase the Biosequence S.A.S. report to view the information.
Incorporation Date:
July 08, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Biosequence S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
95.09%▲
Total operating revenue
95.09%▲
Operating profit (EBIT)
25.1%▲
EBITDA
212.27%▲
Net Profit (Loss) for the Period
66.07%▲
Total assets
-27.77%▼
Total equity
17.35%▲
Operating Profit Margin (ROS)
-2.22%▼
Net Profit Margin
-0.48%▼
Return on Equity (ROE)
4.34%▲
Quick Ratio
0.31%▲
Cash Ratio
0.15%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo